00:50
2026-06-06
letsdatascience.com
artificial-intelligence
Cambridge team tests AI-designed universal vaccine
The University of Cambridge and its spin-out DIOSynVax (DVX) Ltd have completed the first-in-human Phase 1 trial of pEVAC-PS, an AI-designed "universal" Sarbeco coronavirus vaccine. The open-label, doโฆ